RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,498,398 | -53.7% | 891,605 | -30.9% | 0.00% | -33.3% |
| Q2 2023 | $16,195,504 | -29.7% | 1,289,451 | -7.8% | 0.00% | -40.0% |
| Q1 2023 | $23,043,161 | +21.1% | 1,399,099 | +9.9% | 0.01% | +25.0% |
| Q4 2022 | $19,024,821 | -40.4% | 1,273,415 | -10.7% | 0.00% | -42.9% |
| Q3 2022 | $31,906,000 | +98.5% | 1,426,303 | +48.6% | 0.01% | +75.0% |
| Q2 2022 | $16,076,000 | +78.6% | 959,783 | +219.1% | 0.00% | +100.0% |
| Q1 2022 | $9,002,000 | -33.8% | 300,771 | -32.1% | 0.00% | -33.3% |
| Q4 2021 | $13,604,000 | +170.3% | 443,001 | +177.6% | 0.00% | +200.0% |
| Q3 2021 | $5,032,000 | -30.1% | 159,581 | -18.9% | 0.00% | -50.0% |
| Q2 2021 | $7,198,000 | -78.5% | 196,738 | -79.6% | 0.00% | -75.0% |
| Q1 2021 | $33,402,000 | +16.6% | 966,200 | +40.2% | 0.01% | +14.3% |
| Q4 2020 | $28,644,000 | +532.3% | 689,214 | +548.0% | 0.01% | +600.0% |
| Q3 2020 | $4,530,000 | – | 106,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |